Ultrahuman Secures $70 Million in a Strategic Funding Round
Ultrahuman, a prominent healthtech company, has successfully raised $70 million in a funding round led by Qualcomm Ventures. This round also saw significant contributions from Alpha Wave, Blume Ventures, Nexus Venture Partners, Alteria Capital, among other investors. The capital injection marks a pivotal step in Ultrahuman’s growth trajectory, facilitating advancements in their innovative health technologies.
Saga Legal’s Role in the Transaction
Renowned law firm Saga Legal played a critical advisory role in this transaction. The firm’s team diligently managed the documentation, negotiations, and execution of the investment, ensuring a seamless process from initiation to closure. Their collaboration with Ultrahuman’s in-house legal team was instrumental in steering the transaction to a successful close.
Key Players in the Legal Team
The Saga Legal team was spearheaded by Partner Neeraj Vyas, with Senior Associates Ayush Maheshwari and Mehak Chadha providing essential support. On the Ultrahuman side, the transaction was directed by Abhilasha Bhatnagar, General Counsel, alongside Shashank Sharma, Senior Corporate Counsel. Their combined expertise was pivotal in navigating the complexities of the deal.
Ultrahuman’s Vision for Innovation and Expansion
Founded by visionaries Mohit Kumar and Vatsal Singhal, Ultrahuman has carved a niche in the healthtech sector with its advanced smart ring and comprehensive health intelligence ecosystem. The newly acquired funds will bolster Ultrahuman’s commitment to research and development, particularly in areas like sensing technologies, artificial intelligence, miniaturized electronics, and health algorithms. Additionally, the company aims to enhance its Blood Vision blood-testing services and expand the reach of its M1 continuous glucose monitoring platform to international markets.
This strategic investment underscores the growing confidence in Ultrahuman’s potential to revolutionize health technology on a global scale. As they continue to innovate and expand, Ultrahuman is poised to make significant strides in improving health outcomes worldwide.
For those interested in submitting Deals, Columns, or Press Releases to Bar & Bench, please complete the form available here.
